title: Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
abstract: Myocardial cell-replacement therapies are emerging as novel therapeutic paradigms for myocardial repair but are hampered by the lack of sources of autologous human cardiomyocytes. The recent advances in stem cell biology and in transcription factor-based reprogramming strategies may provide exciting solutions to this problem. In the current review, we describe the different reprogramming strategies that can give rise to cardiomyocytes for regenerative medicine purposes. Initially, we describe induced pluripotent stem cell technology, a method by which adult somatic cells can be reprogrammed to yield pluripotent stem cells that could later be coaxed ex vivo to differentiate into cardiomyocytes. The generated induced pluripotent stem cell-derived cardiomyocytes could then be used for myocardial cell transplantation and tissue engineering strategies. We also describe the more recent direct reprogramming approaches that aim to directly convert the phenotype of one mature cell type (fibroblast) to another (cardiomyocyte) without going through a pluripotent intermediate cell type. The advantages and shortcomings of each strategy for cardiac regeneration are discussed, along with the hurdles that need to be overcome on the road to clinical translation.
authors.affiliation: Sohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine and Cardiology Department, Rambam Medical Center, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.
authors.forename: Inbar
authors.initials: I
authors.lastname: Budniatzky
authors.forename: Lior
authors.initials: L
authors.lastname: Gepstein
mesh_terms: D000328:Adult; D000818:Animals; D064592:Autografts; D054337:Cell Dedifferentiation; D006331:Heart Diseases / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000378:metabolism / Q000637:transplantation; D032383:Myocytes, Cardiac / Q000378:metabolism / Q000637:transplantation; D044968:Regenerative Medicine / Q000379:methods*
keywords: Cardiomyocytes; Cell therapy; Direct reprogramming; Heart failure; Induced pluripotent stem cells; Tissue engineering